Dr. Fesler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
232 S Woods Mill Rd
Suite 330
Chesterfield, MO 63017Phone+1 314-205-6737Fax+1 314-205-6247- Is this information wrong?
Summary
- Mark Fesler, MD, is board certified in hematology, oncology and practices at St. Luke’s Center for Cancer Care. Dr. Fesler earned his medical degree at St. Louis University School of Medicine. He completed his residency at University of Colorado Health Sciences Center where he also served as Chief Resident. Dr. Fesler completed his fellowship in hematology
and medical oncology at St. Louis University School of Medicine.
Dr. Fesler specializes in all blood cancers and he has a special interest in the recent transformative developments in both diagnosis and treatment of blood cancer. He has expertise in immunotherapy, cellular therapy/bone marrow transplantation, lymphoma, myeloma, leukemia, and myelodysplastic/ myeloproliferative neoplasms. Dr. Fesler has a long background of research and will continue his research focus at St. Luke’s Hospital. He utilizes an integrated, multidisciplinary, and holistic approach to deliver a tailored care plan focused on the individual person. Dr. Fesler is available for both inpatient and outpatient consultation and both onsite and virtual visits.
Dr. Fesler will be working collaboratively with Dr. Yadira Hurley, a SLUCare dermatopathologist, to provide a multidisciplinary cutaneous lymphoma clinic for patients with blood cancers that affect their skin.
Dr. Fesler is currently accepting new patients at St. Luke’s Center for Cancer Care.
Education & Training
St Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
University of ColoradoResidency, Internal Medicine, 2003 - 2006- Saint Louis University School of MedicineClass of 2003
Certifications & Licensure
MO State Medical License 2008 - 2025
CO State Medical License 2004 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma Start of enrollment: 2006 Jul 01
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma.Xiao Li, Carlos Gaibor, Mark Fesler> ;Cureus. 2023 Sep 1
- 2 citationsSARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema.Mike Fritz, Alex W. Wessel, Gabriela M. Morris, Linda Goldenberg, Mark Fesler, Lokesh A. Rukmangadachar, M. Yadira Hurley, Daniel Tinker> ;JAAD Case Reports. 2021 Nov 6
- Bilateral auricular nodules: A peculiar presentation of systemic mantle cell lymphoma.Mike Fritz, Martin R. Dittmer, Kristin Smith, Katherine Robbins, Linda Goldenberg, Mark Fesler, M. Yadira Hurley, Daniel Tinker> ;JAAD Case Reports. 2021 Jun 2
- Join now to see all
Press Mentions
SSM Health Medical Minute – New Therapy for Blood Cancer Patients Providing ‘Landscape Changing’ ResultsMarch 11th, 2020- Managing Anxiety in the Face of a Cancer DiagnosisOctober 3rd, 2016
Hospital Affiliations
SSM Health Saint Louis University HospitalSaint Louis, Missouri
St. Luke's HospitalChesterfield, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
